Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomised Placebo Controlled Study of OXN PR for Severe Parkinson's Disease Associated Pain

NCT01439100 is registered in ClinicalTrials.gov with Mundipharma Research GmbH & Co KG as lead sponsor.

NCT NCT01439100
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01439100 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomised Placebo Controlled Study of OXN PR for Severe Parkinson's Disease Associated Pain
Lead sponsor
Mundipharma Research GmbH & Co KG
Phase
Phase 3
Overall status
Completed
Start date
October 31, 2011
Completion date
October 31, 2013
Enrollment
172 (estimated)
Sites
31

Conditions

As the registry lists them; a condition with its own page is linked.

parkinson's disease with severe pain